Spero Therapeutics Reschedules Fourth Quarter and Full Year
CAMBRIDGE, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset
Globe Newswire13-03-2023, 19:14
Airshare Continues Growth, Plans to Double Fractional Challenger Fleet with New Agreement Featuring Bombardier’s Challenger 3500 Aircraft 26-07-2023, 17:45